Medical device and MedTech insights, news, tips and more

After a Dramatic Rise, the Average U.S. Medical Radiation Doses Now Are Decreasing 

November 18, 2019

radiation-40263_1280

radiation-40263_1280

The National Council on Radiation Protection and Measurements (NCRP) today issued a new report showing a 15 to 20 % reduction in diagnostic and interventional medical radiation doses to the U.S. population from 2006 to 2016. Except for computed tomography (CT) scans, most medical imaging doses are stable or decreasing. This finding is a contrast to the dramatic rise documented in a 2009 NCRP report, which showed a six-fold increase from the early 1980s to 2006.

The Report, entitled “Medical Radiation Exposure of Patients in the United States,” is a 10-year update to an NCRP report published in 2009. The current report updates medical radiation exposure information with data collected between 2006 and 2016.

“Our report demonstrates that medical radiation doses in the United States are on the decline, which is a positive shift from a decade ago when doses were increasing significantly,” said Dr. Fred Mettler, chair of the NCRP report and Professor Emeritus and Clinical Professor at the Department of Radiology and Nuclear Medicine at the University of New Mexico School of Medicine. “In the Report, we pay particular attention to medical procedures that contribute the largest share of dose and provide information on average doses that patients may experience from a specific examination.”

NCRP’s Report shows that CT scans made up 63 % of collective dose from medical imaging procedures in 2016, compared to 50 % in 2006. While the number of CT scans increased by 20 % over that decade, the overall dose per person for CT procedures was essentially unchanged.

For a number of other modalities, the Report shows the average radiation dose per person has decreased. The Report discusses technological advances that have yielded hardware improvements and protocols, leading to higher quality images at lower doses. In addition, radiography has moved away from standard film and increased use of digital receptors, leading to lower radiation doses for some procedures. Further, efforts by organizations such as the American College of Radiology (ACR), the U.S. Food and Drug Administration (FDA), and the Image Gently®/Step Lightly® Programs have increased awareness and understanding of medical radiation doses and dose optimization and reduction.

“Changes in technology as well as campaigns to increase dose awareness and reduce dose among the medical community and the public seem to be having the desired effect,” said Dr. Mahadevappa Mahesh, co-chair of the NCRP Report and Professor of Radiology and Radiological Science at the Johns Hopkins University School of Medicine. “These data show the medical community can continue to leverage the benefits of radiological procedures for patients while reducing dose.”

See Full Press Release: After a Dramatic Rise, the Average U.S. Medical Radiation Doses Now Are Decreasing | Business Wire


Written by: NCRP


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.